Clinical Trials Logo

Pregnancy Outcome, Live Birth clinical trials

View clinical trials related to Pregnancy Outcome, Live Birth.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00708383 Completed - Infertility Clinical Trials

in Vitro Fertilization (IVF) Media Protein and Live Birth Rates

SSS
Start date: September 2001
Phase: N/A
Study type: Interventional

Human conception in vivo occurs in a complex milieu that includes proteins. It has been speculated that the addition of proteins more complex than human serum albumin to culture media may improve IVF outcomes. Whether the expense, labor and risk of adding additional human-derived protein to IVF media are warranted is a question unanswered. Patients, undergoing routine IVF or ICSI, will be assigned to one of two treatment groups in a randomized, prospective clinical trial . Embryos will be cultured in either media supplemented with human serum albumin (HSA) as a solitary protein supplement or in media supplemented with HSA + SSS from the 2-PN stage until the time of embryo transfer. Clinical endpoints monitored will be implantation rate, clinical pregnancy rate and live birth rate. It is expected that the supplementation of commercial embryo culture media containing HSA with the more complex protein source, SSS, will result in an overall increase in implantation, clinical pregnancy, and live birth rates. In the balance, protein enrichment of media may represent opportunities to simultaneously increase the live birth rate and reduce the incidence of multiple gestations.